Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the German Low Grade Lymphoma Study Group.
暂无分享,去创建一个
W. Klapper | E. Hoster | W. Hiddemann | G. Ott | C. Loddenkemper | T. Barth | M. Dreyling | M. Unterhalt | O. Determann | Heinz Wolfram Bernd | Martin Leo Hansmann